Medtronic plc MDT recently received the FDA’s approval for the Percept RC Deep Brain Stimulation (“DBS”) system. The rechargeable neurostimulator is the latest innovation in the Medtronic ...

Currently, the Medtronic Access controller is the most commonly used DBS patient controller. In practice, we observed that especially elderly patients refuse to use the controller or encounter ...

Despite its benefits, placement of DBS is not without risks (Medtronic, Inc., 2000). The Summary of Safety and Effectiveness Data for Supplemental Premarket Approval Application to the U.S. Food ...

Medical devicemaker Medtronic has had a busy year filled with tech innovation, leadership appointments and restructuring efforts. Here are 19 updates from the company in 2024: 1. Medtronic received ...

Medtronic’s neuroscience portfolio—covering neuromodulation as well as cranial, spinal and specialty therapies—saw its ...

Medtronic is raising its full-year guidance following second-quarter results that came in ahead of the consensus forecast.